title: Hepatitis B complicated focal segmental glomerulosclerosis.
abstract: After the initial report of membranous glomerulopathy due to hepatitis B virus infection by Combes et al, other glomerular diseases - but rarely focal segmental glomerulosclerosis (FSGS) association with HBV infection - have been reported. Herein we present an 8-year-old boy with chronic HBV infection complicated FSGS. The patient was initially regarded as idiopathic FSGS and started on an immunosuppressive schedule. The elevation of liver transaminases in the course of the therapy revealed the immunotolerated perinatal HBV infection. It was considered that immunosuppressive agents have induced viral replication. The treatment was changed to lamivudine alone. The nephrotic syndrome has already been improved with the seroconversion of anti-HBeAg and reduced liver functional tests by the tenth month of the treatment. This case is peculiar for the seldom association of FSGS with chronic HBV infection and treatment modality particularly for the countries where this viral infection is endemic.
authors.affiliation: Pediatric Nephrology Unit, Gulhane Military Medical Academy, Etlik-Ankara - Turkey. onursakallioglu@hotmail.com
authors.forename: O
authors.initials: O
authors.lastname: Sakallioglu
authors.forename: F
authors.initials: F
authors.lastname: Gok
authors.forename: S
authors.initials: S
authors.lastname: Kalman
authors.forename: A E
authors.initials: AE
authors.lastname: Kurekci
authors.forename: O
authors.initials: O
authors.lastname: Gunhan
authors.forename: E
authors.initials: E
authors.lastname: Gokcay
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D004279:DNA, Viral / Q000032:analysis; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D005938:Glucocorticoids; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine